AHA: Consider obesity as CVD risk factor in childrenFebruary 25, 2019PediatricsPatient & Survivor Care
ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patientsFebruary 20, 2019ThrombosisPatient & Survivor Care
Checkpoint inhibitors linked to rare, but serious immune-related side effectsJanuary 15, 2019Patient & Survivor CareB Cell Lymphoma
Poor-prognosis cancers linked to highest suicide risk in first yearJanuary 7, 2019Patient & Survivor Care
Lack of gut diversity hurts survival after HCTDecember 21, 2018Cellular TherapyPatient & Survivor Care
Survivors of childhood Hodgkin lymphoma face 14-fold risk of second cancersDecember 20, 2018Patient & Survivor CarePediatricsHodgkin LymphomaB Cell Lymphoma
Phase 3 data support apixaban for cancer-associated VTEDecember 13, 2018Patient & Survivor CareThrombosis
